The Neuro is patient care, Open Science research and training.

Gary Armstrong

Tiny fish could be the key to an ALS breakthrough

31 May 2022

Gary Armstrong has high praise for zebrafish, a species of fish that he is using to look for new ways to treat ALS, a fatal neurodegenerative disease that has defied a cure and effective treatments.

Multiple ALS projects at The Neuro awarded funding

Published: 15Feb2021

Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease...

Major ALS Research Funding Announced

Published: 23Nov2016

MNI scientists will study stem cells, genetic mutations to develop new treatments...

ALS – Fostering awareness of a devastating disease

Published: 2Jun2017

ALS takes away the patient’s motor functions one at a time, and the progress of finding effective drugs to counter its insidious effects has been slow. June is ALS Month, a good time to update the...

June is ALS Month

Published: 7Jun2018

A look at the latest ALS research and clinical care at The Neuro...

ALS researcher receives important grant

Published: 16Nov2018

Gary Armstrong will use fish models to understand nervous system signaling...

Solving an ALS mystery

12 Jun 2019

Overpowered synaptic activity may lead to motor neuron death

Gary Armstrong: I choose The Neuro

1 Nov 2018

“I’m particularly interested in what’s going wrong at the cellular level in the spinal cord of patients with ALS. The better we can understand defects that arise there, the quicker we can advance...

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top